Immediate Impact
57 standout
Citing Papers
Atopic dermatitis
2025 Standout
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II)
2023 Standout
Works of Steven Watts being referenced
Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase III trials
2020
Clinical trial parameters that influence outcomes in lupus trials that use the systemic lupus erythematosus responder index
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Steven Watts | 328 | 242 | 48 | 197 | 20 | 604 | |
| Richard Casey | 232 | 208 | 79 | 300 | 38 | 701 | |
| Mick van Trotsenburg | 246 | 41 | 30 | 42 | 16 | 604 | |
| A. Cilotti | 326 | 171 | 17 | 89 | 19 | 581 | |
| L.R. Bégin | 134 | 115 | 11 | 63 | 32 | 721 | |
| Marc Gittleman | 316 | 155 | 34 | 196 | 17 | 727 | |
| John B. Malcolm | 104 | 63 | 14 | 79 | 32 | 695 | |
| Brian Murby | 142 | 36 | 63 | 20 | 16 | 583 | |
| H Navratil | 198 | 76 | 9 | 136 | 45 | 585 | |
| Tim Terry | 72 | 89 | 74 | 74 | 27 | 664 | |
| Normand Ayotte | 597 | 181 | 14 | 16 | 18 | 718 |
All Works
Loading papers...